MedTrace Logo

Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery

NCT04284722 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2020-02-26

No results posted yet for this study

Summary

Evaluation of the effect of peri-operative continuation of oral metformin therapy on the incidence of perioperative hyperglycemia compared to standard preoperative cessation of oral metformin therapy 24h before surgery.

Conditions

Interventions

DRUG

Metformin Hydrochloride

Perioperative continuation of oral metformin therapy according to the patient's normal dosage and dosage intervals

Sponsors & Collaborators

  • Kepler University Hospital

    lead OTHER

Principal Investigators

  • Jens Meier, MD · Kepler University Hospital -Dpt. of Anesthesiology & Intensive Care Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-29
Primary Completion
2021-02-28
Completion
2021-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04284722 on ClinicalTrials.gov